Targeting nerve growth factor may cure liver cancerSeptember 19, 2007Nerve growth factor (NGF), as the name says, is an essential peptide factor for the growth and differentiation of neuronal cells. Therefore we can imagine that this growth factor is important for the nervous system including brain. But a recent scientific report published in the October 7 issue of the World Journal of Gastroenterology tells us another surprising and exciting discovery about this growth factor: NGF is positively related with liver cancer, the No.2 killer among all kinds of cancers in the world. This research was collaboration among scientists from National Research Council of Italy, Marino Hospital in Rome, Regina Elena Cancer Institute in Rome, and University of Rome. This fruitful collaboration was under the leadership of Dr Annalucia Serafino, a talented biologist who has made her well-recognized reputation in cancer research and hepatitis C virus research. She is holding a senior researcher position in the national research council in Rome, which plays a similar role as the National Institutes of Health in the United States. With many beautiful pictures of immunohistology, these scientists showed that NGF and its receptor trkANGF were expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma (HCC) while these two molecules are not detected in the liver of healthy people. For a growth factor to affect a cell, there should be its specific receptor expressed on the surface of the target cell. Since both NGF and its specific receptor are abnormally expressed in the liver of patients, NGF seems to be expressed by liver cells to affect themselves (so called autocrine) or to affect adjacent cells (so called paracrine) in patients with liver cirrhosis and/or HCC. These important discoveries indicate that NGF is playing a critical role in the development of liver cirrhosis and its progression towards HCC. Based on this discovery, targeting the NGF or its specific receptor trkANGF in diseased liver may suppress or prevent the development of liver cirrhosis and HCC. In the near future, bioengineers may be able to design a medicine directed to liver to inactivating NGF or its receptor. The discovery reported in this article also opens up the possibility to use NGF in the early diagnosis of liver cirrhosis and HCC because of the high and specific expression of this growth factor in the liver progressing into liver cirrhosis and/or HCC. World Journal of Gastroenterology |
|||||||||||||||||||||
| Related Liver Cirrhosis Current Events and Liver Cirrhosis News Articles The use of stem cells in regenerative medicine may also be detrimental for health The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis. Discovery could improve hepatitis C treatment Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments. What are the risk factors for rebleeding after negative angiography? Acute non-variceal gastrointestinal bleeding accounts for approximately 20% of emergency room visits and 5% of admissions. HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia? Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. New Strategy for Inhibiting Virus Replication Viruses need living cells for replication and production of virus progeny. Thus far, antiviral therapy primarily targets viral factors but often induces therapy resistance. New improved therapies attempt to targets cellular factors that are essential for viral replication. Spot urine test: To monitor dietary sodium compliance in liver disease patients? A research article to be published on August 7 , 2009 in the World Journal of Gastroenterology addresses this question. Hepatitis C infection: treatment options equally effective, likelihood of success known early on Results of a long-awaited study of 3,070 American adults at Johns Hopkins and 118 other U.S. medical centers show that treatment with either of the two standard antiviral drug therapies is safe and offers the best way for people infected with hepatitis C to prevent liver scarring, organ failure and death. Study shows 1 in 25 deaths worldwide attributable to alcohol Research from Canada's own Centre for Addiction and Mental Health (CAMH) featured in this week's edition of the Lancet shows that worldwide, 1 in 25 deaths are directly attributable to alcohol consumption. An alternative treatment for hypervascular hepatocellular carcinoma HCC is the fifth most common cancer in the world and the third most frequent cause of cancer-related death. Only about 20% of HCC patients are eligible for surgical resection. What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus? Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. More Liver Cirrhosis Current Events and Liver Cirrhosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||